{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:01:43Z","timestamp":1793714503082,"version":"4.6.1"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:p>The classification of salivary gland carcinomas has become increasingly specific over the last decade with the definition of new tumor types, documentation of novel molecular and immunohistochemical findings, and development of more refined diagnostic criteria. In this setting, it is unclear how many salivary tumors still cannot be easily categorized\u2014and whether such tumors represent undifferentiated malignancies or include additional definable entities. Relying largely on current classification schemes and contemporary immunohistochemical panels, we reassessed salivary tumors previously diagnosed as adenocarcinoma, not otherwise specified (ACA NOS) from 2 large academic medical centers. Fifty-seven ACA NOS (72%) could be reclassified as more specific entities including 31 salivary duct carcinomas (39%), 7 polymorphous adenocarcinomas (9%), 5 epithelial-myoepithelial carcinomas (6%), 4 myoepithelial carcinomas (5%), 4 secretory carcinomas (5%), 1 acinic cell carcinoma (1%), 1 basal cell adenocarcinoma (1%), 1 intraductal carcinoma (1%), and 1 clear cell carcinoma (1%) as well as 2 metastatic squamous cell carcinomas (3%). Of reclassified cases, 21 (37%) represented variant histologies within these categories. ACA NOS comprised 11% of salivary malignancies before reclassification, but only 4% after reclassification. The remaining 22 ACA NOS demonstrated heterogeneous features, with an association between histologic grade and clinical outcome. In effect, ACA NOS is becoming a bygone entity as modern classification schemes and ancillary techniques now permit more specific typing of a majority of these tumors, potentially facilitating more specific prognostication and treatment. Additional distinctive entities such as mucinous adenocarcinoma may still be definable within the ACA NOS category.<\/jats:p>","DOI":"10.1097\/pas.0000000000001636","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:08:19Z","timestamp":1607299699000},"page":"753-764","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":30,"title":["The Decline of Salivary Adenocarcinoma Not Otherwise Specified as a Tumor Entity"],"prefix":"10.1097","volume":"45","author":[{"given":"Lisa M.","family":"Rooper","sequence":"first","affiliation":[{"name":"Pathology"},{"name":"Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mena","family":"Mansour","sequence":"additional","affiliation":[{"name":"Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raluca","family":"Yonescu","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram R.","family":"Oliai","sequence":"additional","affiliation":[{"name":"ProPath"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin A.","family":"Bishop","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Westra","sequence":"additional","affiliation":[{"name":"Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,12,4]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/PAS.0000000000001273","article-title":"Microsecretory adenocarcinoma: a novel salivary gland tumor characterized by a recurrent MEF2C-SS18 fusion","volume":"43","author":"Bishop","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0b013e3181d9efcc","article-title":"Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity","volume":"34","author":"Skalova","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/gcc.20881","article-title":"EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland","volume":"50","author":"Antonescu","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41467-018-08069-x","article-title":"Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands","volume":"10","author":"Haller","year":"2019","journal-title":"Nat Commun"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/PAS.0000000000001301","article-title":"NCOA4-RET and TRIM27-RET are characteristic gene fusions in salivary intraductal carcinoma, including invasive and metastatic tumors: is \u201cintraductal\u201d correct?","volume":"43","author":"Skalova","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/PAS.0000000000001133","article-title":"molecular profiling of salivary gland intraductal carcinoma revealed a subset of tumors harboring NCOA4-RET and novel TRIM27-RET fusions: a report of 17 cases","volume":"42","author":"Skalova","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/PAS.0000000000000952","article-title":"Recurrent RET gene rearrangements in intraductal carcinomas of salivary gland","volume":"42","author":"Weinreb","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/ng.3096","article-title":"Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands","volume":"46","author":"Weinreb","year":"2014","journal-title":"Nat Genet"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/gcc.22195","article-title":"Novel PRKD gene rearrangements and variant fusions in cribriform adenocarcinoma of salivary gland origin","volume":"53","author":"Weinreb","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s12105-013-0506-4","article-title":"HRAS mutations in epithelial-myoepithelial carcinoma","volume":"8","author":"Chiosea","year":"2014","journal-title":"Head Neck Pathol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/PAS.0000000000000933","article-title":"Epithelial-myoepithelial carcinoma: frequent morphologic and molecular evidence of preexisting pleomorphic adenoma, common HRAS mutations in PLAG1-intact and HMGA2-intact cases, and occasional TP53, FBXW7, and SMARCB1 alterations in high-grade cases","volume":"42","author":"El Hallani","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/PAS.0000000000000932","article-title":"MAML2 rearrangements in variant forms of mucoepidermoid carcinoma: ancillary diagnostic testing for the ciliated and warthin-like variants","volume":"42","author":"Bishop","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/PAS.0000000000000507","article-title":"Warthin-like mucoepidermoid carcinoma: a combined study of fluorescence in situ hybridization and whole-slide imaging","volume":"39","author":"Ishibashi","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"suppl 1","key":"R14-20250608","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1007\/s12105-013-0461-0","article-title":"Oncocytic and apocrine epithelial myoepithelial carcinoma: novel variants of a challenging tumor","volume":"7","author":"Seethala","year":"2013","journal-title":"Head Neck Pathol"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1097\/PAS.0b013e3181de3021","article-title":"A reappraisal of the MECT1\/MAML2 translocation in salivary mucoepidermoid carcinomas","volume":"34","author":"Seethala","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/PAS.0000000000000413","article-title":"Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression","volume":"39","author":"Williams","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/PAS.0000000000001218","article-title":"Misinterpreted myoepithelial carcinoma of salivary gland: a challenging and potentially significant pitfall","volume":"43","author":"Xu","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/PAS.0b013e3182841554","article-title":"Most nonparotid \u201cacinic cell carcinomas\u201d represent mammary analog secretory carcinomas","volume":"37","author":"Bishop","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/lary.22419","article-title":"Prospective testing of mucoepidermoid carcinoma for the MAML2 translocation: clinical implications","volume":"122","author":"Chiosea","year":"2012","journal-title":"Laryngoscope"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/PAS.0b013e318242a5b0","article-title":"The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma","volume":"36","author":"Chiosea","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humpath.2016.06.029","article-title":"Reevaluation of MAML2 fusion-negative mucoepidermoid carcinoma: a subgroup being actually hyalinizing clear cell carcinoma of the salivary gland with EWSR1 translocation","volume":"61","author":"Hsieh","year":"2017","journal-title":"Hum Pathol"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.oraloncology.2011.04.020","article-title":"Salivary gland carcinoma in Denmark 1990-2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA)","volume":"47","author":"Bjorndal","year":"2011","journal-title":"Oral Oncol"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0002-9610(82)90416-0","article-title":"Adenocarcinoma of salivary origin. Clinicopathologic study of 204 patients","volume":"144","author":"Spiro","year":"1982","journal-title":"Am J Surg"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/(SICI)1097-0347(199805)20:3<204::AID-HED4>3.0.CO;2-4","article-title":"Parotid gland tumors: histologic reevaluation and reclassification of 478 cases","volume":"20","author":"van der Wal","year":"1998","journal-title":"Head Neck"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S1368-8375(02)00007-6","article-title":"Carcinoma of the parotid and submandibular glands\u2014a study of survival in 2465 patients","volume":"38","author":"Wahlberg","year":"2002","journal-title":"Oral Oncol"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0030-4220(88)90240-X","article-title":"Tumors of the intraoral minor salivary glands: a demographic and histologic study of 426 cases","volume":"66","author":"Waldron","year":"1988","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hed.24382","article-title":"Predictors of survival in parotid adenocarcinoma not otherwise specified: a National Cancer Database study of 3155 patients","volume":"38","author":"Zhan","year":"2016","journal-title":"Head Neck"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.oraloncology.2015.03.005","article-title":"Prognostic factors in adenocarcinoma of the salivary glands","volume":"51","author":"Huang","year":"2015","journal-title":"Oral Oncol"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.5858\/2004-128-1385-SANOSA","article-title":"Salivary adenocarcinoma, not otherwise specified: a collection of orphans","volume":"128","author":"Li","year":"2004","journal-title":"Arch Pathol Lab Med"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/PAS.0000000000000977","article-title":"Clear cell carcinoma of salivary glands is frequently p16 positive: a pitfall in the interpretation of oropharyngeal biopsies","volume":"42","author":"Bishop","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s12105-014-0518-8","article-title":"Secretory myoepithelial carcinoma: a histologic and molecular survey and a proposed nomenclature for mucin producing signet ring tumors","volume":"8","author":"Bastaki","year":"2014","journal-title":"Head Neck Pathol"},{"issue":"suppl 1","key":"R33-20250608","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1007\/s12105-013-0464-x","article-title":"Mucinous myoepithelioma, a recently described new myoepithelioma variant","volume":"7","author":"Gnepp","year":"2013","journal-title":"Head Neck Pathol"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/his.12987","article-title":"Salivary duct carcinoma with rhabdoid features: a salivary counterpart of pleomorphic lobular carcinoma of the breast","volume":"70","author":"Kusafuka","year":"2017","journal-title":"Histopathology"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2559.2010.03682.x","article-title":"Ductal adenomas of salivary gland showing features of striated duct differentiation (\u2018striated duct adenoma\u2019): a report of six cases","volume":"57","author":"Weinreb","year":"2010","journal-title":"Histopathology"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1016\/j.oooo.2017.12.017","article-title":"Sclerosing microcystic adenocarcinoma of the tongue: a report of 2 further cases and review of the literature","volume":"125","author":"Wood","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.humpath.2013.03.017","article-title":"Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma","volume":"44","author":"Bishop","year":"2013","journal-title":"Hum Pathol"},{"key":"R38-20250608","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/PAI.0000000000000222","article-title":"Comparison of p63 and p40 (DeltaNp63) as basal, squamoid, and myoepithelial markers in salivary gland tumors","volume":"24","author":"Owosho","year":"2016","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R39-20250608","doi-asserted-by":"crossref","first-page":"801","DOI":"10.5858\/1999-123-0801-TMIIBA","article-title":"The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma","volume":"123","author":"Prasad","year":"1999","journal-title":"Arch Pathol Lab Med"},{"key":"R40-20250608","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12105-014-0554-4","article-title":"Polymorphous low grade adenocarcinoma has a consistent p63+\/p40\u2212 immunophenotype that helps distinguish it from adenoid cystic carcinoma and cellular pleomorphic adenoma","volume":"9","author":"Rooper","year":"2015","journal-title":"Head Neck Pathol"},{"key":"R41-20250608","article-title":"Immunohistochemistry surrogates for molecular alterations: a new paradigm in salivary gland tumor cytopathology?","author":"Bishop","year":"2020","journal-title":"Cancer Cytopathol"},{"key":"R42-20250608","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1097\/PAS.0000000000001279","article-title":"Nuclear NR4A3 immunostaining is a specific and sensitive novel marker for acinic cell carcinoma of the salivary glands","volume":"43","author":"Haller","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R43-20250608","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/PAS.0000000000000088","article-title":"Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, beta-catenin, EGFR, and CCND1 genes","volume":"38","author":"Skalova","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R44-20250608","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12105-020-01140-4","article-title":"Salivary gland cancer in the era of routine next-generation sequencing","volume":"14","author":"Todorovic","year":"2020","journal-title":"Head Neck Pathol"},{"key":"R45-20250608","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/hed.25035","article-title":"Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: a nationwide case series of 35 patients in The Netherlands","volume":"40","author":"Boon","year":"2018","journal-title":"Head Neck"},{"key":"R46-20250608","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/annonc\/mdx771","article-title":"A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma","volume":"29","author":"Fushimi","year":"2018","journal-title":"Ann Oncol"},{"key":"R47-20250608","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejca.2018.12.035","article-title":"Adjuvant androgen deprivation therapy for poor-risk, androgen receptor-positive salivary duct carcinoma","volume":"110","author":"van Boxtel","year":"2019","journal-title":"Eur J Cancer"},{"key":"R48-20250608","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1634\/theoncologist.2019-0841","article-title":"The benefits of adjuvant trastuzumab for HER-2-positive salivary gland cancers","volume":"25","author":"Hanna","year":"2020","journal-title":"Oncologist"},{"key":"R49-20250608","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1200\/JCO.18.00545","article-title":"Phase II trial of trastuzumab and docetaxel in patients with human epidermal growth factor receptor 2-positive salivary duct carcinoma","volume":"37","author":"Takahashi","year":"2019","journal-title":"J Clin Oncol"},{"key":"R50-20250608","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children","volume":"378","author":"Drilon","year":"2018","journal-title":"N Engl J Med"},{"key":"R51-20250608","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2559.1999.00792.x","article-title":"Cribriform adenocarcinoma of the tongue: a hitherto unrecognized type of adenocarcinoma characteristically occurring in the tongue","volume":"35","author":"Michal","year":"1999","journal-title":"Histopathology"},{"key":"R52-20250608","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1097\/PAS.0000000000000705","article-title":"Predictors of outcome in the phenotypic spectrum of polymorphous low-grade adenocarcinoma (PLGA) and cribriform adenocarcinoma of salivary gland (CASG): a retrospective study of 69 patients","volume":"40","author":"Xu","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R53-20250608","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2015.03.054","article-title":"Myoepithelial carcinoma of the salivary glands: a clinicopathologic study of 29 patients","volume":"73","author":"Wang","year":"2015","journal-title":"J Oral Maxillofac Surg"},{"key":"R56-20250608","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12105-017-0795-0","article-title":"Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: tumors of the salivary gland","volume":"11","author":"Seethala","year":"2017","journal-title":"Head Neck Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001636","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T22:05:24Z","timestamp":1749420324000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001636"}},"subtitle":["Reclassification Using Contemporary Immunohistochemical Profiling and Diagnostic Criteria"],"short-title":[],"issued":{"date-parts":[[2020,12,4]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001636","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,4]]}}}